Asklepieion General Hospital   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Voula Greece (1985)

Organization Overview

First Clinical Trial
2005
NCT02619032
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Asklepeion Voulas General Hospital | Asklepieion Voulas General Hospital | Asklepiion General Hospital of Voula

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Agnosia (Phase 3)

Down Syndrome (Phase 2)

Hallux Valgus (Phase 2)

Rotator Cuff Injuries (Phase 2)

Shoulder Dislocation (Phase 2)

Shoulder Fractures (Phase 2)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 11
  • # of Trial APIs: 12